BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16176307)

  • 1. Platelet-derived VWF-cleaving metalloprotease ADAMTS-13.
    Liu L; Choi H; Bernardo A; Bergeron AL; Nolasco L; Ruan C; Moake JL; Dong JF
    J Thromb Haemost; 2005 Nov; 3(11):2536-44. PubMed ID: 16176307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.
    Dong JF; Moake JL; Nolasco L; Bernardo A; Arceneaux W; Shrimpton CN; Schade AJ; McIntire LV; Fujikawa K; López JA
    Blood; 2002 Dec; 100(12):4033-9. PubMed ID: 12393397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor.
    Dong JF; Moake JL; Bernardo A; Fujikawa K; Ball C; Nolasco L; López JA; Cruz MA
    J Biol Chem; 2003 Aug; 278(32):29633-9. PubMed ID: 12775718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations among normal individuals in the cleavage of endothelial-derived ultra-large von Willebrand factor under flow.
    Dong JF; Whitelock J; Bernardo A; Ball C; Cruz MA
    J Thromb Haemost; 2004 Aug; 2(8):1460-6. PubMed ID: 15304055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions.
    Dong JF
    J Thromb Haemost; 2005 Aug; 3(8):1710-6. PubMed ID: 16102037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfide bond reduction of von Willebrand factor by ADAMTS-13.
    Yeh HC; Zhou Z; Choi H; Tekeoglu S; May W; Wang C; Turner N; Scheiflinger F; Moake JL; Dong JF
    J Thromb Haemost; 2010 Dec; 8(12):2778-88. PubMed ID: 20946172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium maintains endothelial integrity, up-regulates proteolysis of ultra-large von Willebrand factor, and reduces platelet aggregation under flow conditions.
    Dong JF; Cruz MA; Aboulfatova K; Martin C; Choi H; Bergeron AL; Martini SR; Kroll MH; Kent TA
    Thromb Haemost; 2008 Mar; 99(3):586-93. PubMed ID: 18327408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura and anti-thrombotic therapy targeted to von Willebrand factor.
    Zhou Z; Dong JF
    Curr Vasc Pharmacol; 2012 Nov; 10(6):762-6. PubMed ID: 22022775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and breakdown of soluble ultralarge von Willebrand factor multimers.
    Turner N; Nolasco L; Moake J
    Semin Thromb Hemost; 2012 Feb; 38(1):38-46. PubMed ID: 22314602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of naturally occurring mutations in CUB-1 domain on synthesis, stability, and activity of ADAMTS-13.
    Zhou Z; Jing H; Tao Z; Choi H; Aboulfatova K; Moake J; Li R; Dong JF
    Thromb Res; 2009 Jul; 124(3):323-7. PubMed ID: 19027144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions.
    Tao Z; Peng Y; Nolasco L; Cal S; Lopez-Otin C; Li R; Moake JL; López JA; Dong JF
    Blood; 2005 Dec; 106(13):4139-45. PubMed ID: 16141351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of platelet strings and microthrombi in the presence of ADAMTS-13 inhibitor does not require P-selectin or beta3 integrin.
    Chauhan AK; Goerge T; Schneider SW; Wagner DD
    J Thromb Haemost; 2007 Mar; 5(3):583-9. PubMed ID: 17166247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS-13 activity in the presence of elevated von Willebrand factor levels as a novel mechanism of residual platelet reactivity in high risk coronary patients on antiplatelet treatment.
    Marcucci R; Cesari F; Cinotti S; Paniccia R; Gensini GF; Abbate R; Gori AM
    Thromb Res; 2008; 123(1):130-6. PubMed ID: 18603284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers.
    Nolasco LH; Turner NA; Bernardo A; Tao Z; Cleary TG; Dong JF; Moake JL
    Blood; 2005 Dec; 106(13):4199-209. PubMed ID: 16131569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells.
    López JA; Dong JF
    Semin Hematol; 2004 Jan; 41(1):15-23. PubMed ID: 14727255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shear stress and the role of high molecular weight von Willebrand factor multimers in thrombus formation.
    López JA; Dong JF
    Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S11-6. PubMed ID: 15849521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tranexamic acid on endothelial von Willebrand factor/ADAMTS-13 response to in vitro shock conditions.
    Diebel LN; Liberati DM
    J Trauma Acute Care Surg; 2023 Feb; 94(2):273-280. PubMed ID: 36322025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets.
    Suzuki M; Murata M; Matsubara Y; Uchida T; Ishihara H; Shibano T; Ashida S; Soejima K; Okada Y; Ikeda Y
    Biochem Biophys Res Commun; 2004 Jan; 313(1):212-6. PubMed ID: 14672719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant ADAMTS-13 Improves Survival of Mice Subjected to Endotoxemia.
    Gao D; Zhou Z; Ma R; Wu H; Nguyen T; Liu L; Dong J
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble plasma-derived von Willebrand factor assembles to a haemostatically active filamentous network.
    Barg A; Ossig R; Goerge T; Schneider MF; Schillers H; Oberleithner H; Schneider SW
    Thromb Haemost; 2007 Apr; 97(4):514-26. PubMed ID: 17393012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.